Defining a reference set to support methodological research in drug safety

PB Ryan, MJ Schuemie, E Welebob, J Duke… - Drug safety, 2013 - Springer
Background Methodological research to evaluate the performance of methods requires a
benchmark to serve as a referent comparison. In drug safety, the performance of analyses of …

Methods for safety signal detection in healthcare databases: a literature review

M Arnaud, B Bégaud, N Thurin, N Moore… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: With increasing availability, the use of healthcare databases as complementary
data source for drug safety signal detection has been explored to circumvent the limitations …

[HTML][HTML] How confident are we about observational findings in healthcare: a benchmark study

MJ Schuemie, MS Cepeda, MA Suchard… - Harvard data science …, 2020 - ncbi.nlm.nih.gov
Healthcare professionals increasingly rely on observational healthcare data, such as
administrative claims and electronic health records, to estimate the causal effects of …

A comparison of the empirical performance of methods for a risk identification system

PB Ryan, PE Stang, JM Overhage, MA Suchard… - Drug safety, 2013 - Springer
Background Observational healthcare data offer the potential to enable identification of risks
of medical products, and the medical literature is replete with analyses that aim to …

Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest

RD Boyce, PB Ryan, GN Norén, MJ Schuemie, C Reich… - Drug safety, 2014 - Springer
The entire drug safety enterprise has a need to search, retrieve, evaluate, and synthesize
scientific evidence more efficiently. This discovery and synthesis process would be greatly …

[HTML][HTML] Toward multimodal signal detection of adverse drug reactions

R Harpaz, W DuMouchel, M Schuemie… - Journal of biomedical …, 2017 - Elsevier
Objective Improving mechanisms to detect adverse drug reactions (ADRs) is key to
strengthening post-marketing drug safety surveillance. Signal detection is presently …

Electronic health data for postmarket surveillance: a vision not realized

TJ Moore, CD Furberg - Drug Safety, 2015 - Springer
What has been learned about electronic health data as a primary data source for regulatory
decisions regarding the harms of drugs? Observational studies with electronic health data …

Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databases

MJ Schuemie, R Gini, PM Coloma, H Straatman… - Drug safety, 2013 - Springer
Abstract Background The Observational Medical Outcomes Partnership (OMOP) has just
completed a large scale empirical evaluation of statistical methods and analysis choices for …

Computational approaches for pharmacovigilance signal detection: toward integrated and semantically-enriched frameworks

VG Koutkias, MC Jaulent - Drug safety, 2015 - Springer
Computational signal detection constitutes a key element of postmarketing drug monitoring
and surveillance. Diverse data sources are considered within the 'search space'of …

The State of Use and Utility of Negative Controls in Pharmacoepidemiologic Studies

Z Zafari, J Park, CH Shah, S Dosreis… - American Journal of …, 2024 - academic.oup.com
Uses of real-world data in drug safety and effectiveness studies are often challenged by
various sources of bias. We undertook a systematic search of the published literature …